72086-72-7

Basic information

• Product Name: BOC-GLU-OME
• Synonyms: BOC-L-GLU-OME;BOC-L-GLUTAMIC ACID METHYL ESTER;BOC-L-GLUTAMIC ACID ALPHA-METHYL ESTER;BOC-GLU-OME;BOC-GLUTAMIC ACID-OME;N-ALPHA-T-BUTOXYCARBONYL-L-GLUTAMIC ACID ALPHA-METHYL ESTER;L-Glutamic acid, N-[(1,1-dimethylethoxy)carbonyl]-,1-methyl ester;Boc-L-glutamicacida-methylester
• CAS NO: 72086-72-7
• Molecular Formula: C₁₁H₁₉NO₆
• Molecular Weight: 261.27
• Product Categories: Amino Acids & Derivatives;Enzyme substrates
• Mol File: 72086-72-7.mol

Chemical Properties

• Melting Point: 119-123℃
• Boiling Point: 428.4 °C at 760 mmHg
• Flash Point: 212.9 °C
• Appearance: /
• Density: 1.182 g/cm³
• Storage Temp.: 2-8°C
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 4.48±0.10(Predicted)
• CAS DataBase Reference: BOC-GLU-OME(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-GLU-OME(72086-72-7)
• EPA Substance Registry System: BOC-GLU-OME(72086-72-7)

Safety Data

• Hazardous Substances Data: 72086-72-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
BOC-GLU-OME is used as a pharmaceutical intermediate for the synthesis of various drugs and drug candidates. Its unique structure and properties make it a valuable building block in the development of new therapeutic agents.
Used in Research and Development:
BOC-GLU-OME is used as a research tool in the study of glutamate receptors and their role in various physiological and pathological processes. It helps researchers to better understand the mechanisms of action and potential therapeutic applications of glutamate-targeting drugs.
Used in Biochemistry and Molecular Biology:
BOC-GLU-OME is used as a reagent in biochemical and molecular biology experiments, such as enzyme assays, protein synthesis, and gene expression studies. Its ability to undergo carboxylation makes it a useful probe for investigating the activity and regulation of enzymes involved in these processes.

Upstream product

• 1070-19-5 N-(tert-butyloxycarbonyl) azide 
• 5672-83-3 Z-L-GluOMe 
• 13574-13-5 Boc-Glu(OBzl)-OH 
• 59936-29-7 (S)-N-(tert-butoxycarbonyl)proline methyl ester 
• 67-56-1 methanol 
• 2419-94-5 Boc-Glu 
• 24424-99-5 di-tert-butyl dicarbonate 
• 59279-60-6 dimethyl (2S)-2-[(tert-butoxycarbonyl)amino]pentanedioate 
• 219617-08-0 dimethyl (2S)-2-{(tert-butoxy)-N-[(tert-butyl)oxycarbonyl]carbonylamino}butanedioate 
• 75-77-4 chloro-trimethyl-silane 
• 56-86-0 L-glutamic acid 
• 1676-73-9 L-glutamic acid γ-benzyl ester 
• 59279-58-2 N^α-tert-butyloxycarbonyl-γ-benzyloxycarbonyl-L-glutamic acid methyl ester 
• 104706-58-3 Boc-Glu(OBzl)-OBt 

Downstream Products

• 142165-88-6 3-((S)-4-tert-Butoxycarbonylamino-4-methoxycarbonyl-butyrylamino)-benzoic acid ethyl ester 
• 181622-69-5 (S)-4-(4-Benzylsulfanyl-phenylcarbamoyl)-2-tert-butoxycarbonylamino-butyric acid methyl ester 
• 181622-66-2 (S)-2-[3-((S)-4-tert-Butoxycarbonylamino-4-methoxycarbonyl-butyrylamino)-benzoylamino]-pentanedioic acid diethyl ester 
• 181622-63-9 (S)-2-tert-Butoxycarbonylamino-4-(4-hydroxy-phenylcarbamoyl)-butyric acid methyl ester 
• 181622-62-8 (S)-2-tert-Butoxycarbonylamino-4-(3-hydroxy-phenylcarbamoyl)-butyric acid methyl ester 
• 181622-56-0 (S)-2-tert-Butoxycarbonylamino-4-(3-cyano-phenylcarbamoyl)-butyric acid methyl ester 
• 181622-57-1 (S)-2-tert-Butoxycarbonylamino-4-(4-cyano-phenylcarbamoyl)-butyric acid methyl ester 
• 181622-55-9 (S)-2-tert-Butoxycarbonylamino-4-(2-cyano-phenylcarbamoyl)-butyric acid methyl ester 
• 194206-03-6 methyl N²-(tert-butoxycarbonyl)-N⁵-phenyl-L-glutaminate 
• 298186-92-2 11β-{4-((4(S)-t-Butoxycarbonylamino-4(S)-methoxycarbonyl)butyryl-methyl-amino)phenyl}-17β-hydroxy-17α-(1-propynyl)estra-4,9-dien-3-one 
• 945492-91-1 (S)-N¹-allyl-N²-Boc-N¹-(o-nitrobenzenesulfonyl)-5-(triisopropylsilyloxy)pentane-1,2-diamine 
• 945492-88-6 C₂₃H₄₁N₃O₅SSi 
• 945493-37-8 methyl (S)-2-[(N-(o-nitrobenzenesulfonyl)amino)-5-(triisopropylsilyloxy)]pentanoate 
• 945493-38-9 (2S)-2-[(N-(o-nitrobenzenesulfonyl)amino)-N-allylamino]-5-(triisopropylsilyloxy)pentanoate 

Relevant articles and documents

Synthesis of l -Kynurenine and Homo- l -Kynurenine via an Aza-Fries Rearrangement

l -Kynurenine, a non-proteinogenic amino acid, is the primary metabolite of tryptophan via the kynurenine pathway. Kynurenine is involved in a variety of biological processes occurring in the human body, notably in the central nervous system. Thus, the st

Synthesis and Biological Evaluation of a Library of AGE-Related Amino Acid Triazole Crosslinkers

Three N-Boc-protected amino acids, l-serine, l-aspartic, and l-glutamic acid, were either converted into their methyl azidoalkanoates or various alkynes via Bestmann-Ohira strategy or via reaction with propargylamine and propargyl bromide, respectively. The Cu-catalyzed click reaction provided a library of amino acid based triazoles, which were further N-methylated to triazolium iodides or deprotected and precipitated as free amino acid triazole dihydrochlorides. The biological properties of all derivatives were investigated by cytotoxicity assay (against L929 mouse fibroblasts) and broth microdilution method (E. coli ΔTolC and S. aureus). First results reveal complete inactivity for triazolium iodides with cell viabilities and microbial growths nearly 100 %, indicating them as possible analogs of advanced glycation endproducts (AGEs).

An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity

Pin1 (protein interacting with never in mitosis A-1) is a member of the peptidyl prolyl isomerase (PPIase) family, and catalyzes cis-trans isomerization of pThr/Ser-Pro amide bonds. Because Pin1 is overexpressed in various cancer cell lines and promotes c

Thaxtomin A and its stereoisomers of the synthesis method

The invention relates to Thaxtomin A and a synthesis method of a stereisomer of Thaxtomin A. The chemical constructions of Thaxtomin A and the stereisomer are as shown in the specification. The invention further provides a synthesis method of the stereisomer. The synthesis route has the characteristics of being efficient, and the stereisomer can be spliced by recrystallization, which is beneficial to mass production of target products.

Synthesis of rhodotorulic acid and its 1,4-dimethylated derivative

Facile syntheses of rhodotorulic acid, isolated from Rhodotorula pilimanae as a siderophore, and its 1,4-dimethylated derivative have been achieved by microwave-assisted cyclization of the corresponding dipeptide precursors.

Synthesis of triazole cages containing C3-symmetric α-cyclic tripeptide scaffold

Two water-soluble C3-symmetric 1,2,3-triazole cages containing α-cyclic tripeptide were efficiently synthesized. The key steps include a click reaction to incorporate l-glutamic or l-aspartic acids to a tripodal linker and a unique one-pot cyclotrimerization.

BORON CONTAINING POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTICS USES THEREOF

Disclosed herein are polybasic bacterial efflux pump inhibitors containing boronic acid functionality and theft methods of synthesis, methods of use, and pharmaceutical compositions. Some embodiments include methods of treating or preventing a bacterial infection by co-administering to a subject infected with bacteria or at risk of infection with bacteria the efflux pump inhibitor with another anti-bacterial agent

PYRIDINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC RING AND gamma-GLUTAMYLAMINO GROUP, AND ANTIFUNGAL AGENTS CONTAINING SAME

The present invention provides an antifungal agent which has excellent antifungal action, and which is also excellent in terms of its properties, and in particular its solubility in water and safety. The present invention discloses a compound represented

POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF

Disclosed are compounds having polybasic functionalities. The compounds inhibit bacterial efflux pump inhibitors and are used in combination with an anti-bacterial agent to treat or prevent bacterial infections. These combinations can be effective against bacterial infections that have developed resistance to anti-bacterial agents through an efflux pump mechanism.

Ruthenium tetroxide oxidation of cyclic N-acylamines by a single layer method: formation of ω-amino acids

The ruthenium tetroxide oxidation of cyclic N-acyl amines by a 10% NaIO4 aqueous solution containing tert-butanol as a single layer system resulted in the endo-cyclic C-N bond cleavage to afford the ω-amino acids as almost sole products in good yields, while a similar oxidation under the double layer using a NaIO4 aqueous solution, and ethyl acetate gave the N-acyl lactams.